Picture of EyePoint logo

EYPT EyePoint Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for EyePoint, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-58.4-102-70.8-131-232
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items7.2937.813.230.823
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.74-3.0259-27.8-33.8
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-50.1-651.88-126-240
Capital Expenditures-0.156-2.15-3.48-4.05-3.28
Purchase of Fixed Assets
Other Investing Cash Flow Items-33-15.10.168-21571.9
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-33.1-17.3-3.31-21968.6
Financing Cash Flow Items-0.15-3.19-1.97-5.18-1.93
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities217-0.69187164174
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash134-83186-1822.12